361551 Sigma-AldrichGSK-3 Inhibitor X - CAS 740841-15-0 - Calbiochem
The GSK-3 Inhibitor X, also referenced under CAS 740841-15-0, controls the biological activity of GSK-3. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
More>> The GSK-3 Inhibitor X, also referenced under CAS 740841-15-0, controls the biological activity of GSK-3. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Less<<Synonyms: (2ʹZ,3ʹE)-6-Bromoindirubin-3ʹ-acetoxime, BIO-Acetoxime
Recommended Products
Overview
| Replacement Information | 
|---|
Key Spec Table
| CAS # | Empirical Formula | 
|---|---|
| 740841-15-0 | C₁₈H₁₂BrN₃O₃ | 
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 361551-1MG | 
 | Plastic ampoule | 1 mg | 
 | — | 
| Description | |
|---|---|
| Overview | An acetoxime analog of BIO, GSK-3 Inhibitor IX (Cat. No. 361550) that exhibits greater selectivity for GSK-3α/β (IC50 = 10 nM) over Cdk5/p25, Cdk2/A and Cdk1/B (IC50 = 2.4 µM, 4.3 µM and 63 µM, respectively). Weakly affects the activities of Cdk4/D1 and many other kinases (IC50 ≥ 10 µM). Also acts as an aryl hydrocarbon receptor agonist in both yeast (EC50 ≥ 0.1 µM) and mammalian (EC50 = 0.16 µM) reporter systems. | 
| Catalogue Number | 361551 | 
| Brand Family | Calbiochem® | 
| Synonyms | (2ʹZ,3ʹE)-6-Bromoindirubin-3ʹ-acetoxime, BIO-Acetoxime | 
| References | |
|---|---|
| References | Knockaert, M., et al. 2004. Oncogene 23, 4400. Polychronopoulos, P., et al. 2004. J. Med. Chem. 47, 935. Meijer, L., et al. 2003. Chem. Biol. 10, 1255. | 
| Product Information | |
|---|---|
| CAS number | 740841-15-0 | 
| ATP Competitive | N | 
| Form | Dark purple solid | 
| Hill Formula | C₁₈H₁₂BrN₃O₃ | 
| Chemical formula | C₁₈H₁₂BrN₃O₃ | 
| Reversible | N | 
| Structure formula Image | |
| Quality Level | MQ100 | 
| Applications | 
|---|
| Biological Information | |
|---|---|
| Primary Target | GSK-3α/β | 
| Primary Target IC<sub>50</sub> | 10 nM against GSK-3α/β | 
| Purity | ≥95% by HPLC | 
| Physicochemical Information | |
|---|---|
| Cell permeable | N | 
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN | 
| 361551-1MG | 04055977214093 | 
Documentation
GSK-3 Inhibitor X - CAS 740841-15-0 - Calbiochem SDS
| Title | 
|---|
GSK-3 Inhibitor X - CAS 740841-15-0 - Calbiochem Certificates of Analysis
| Title | Lot Number | 
|---|---|
| 361551 | 
References
| Reference overview | 
|---|
| Knockaert, M., et al. 2004. Oncogene 23, 4400. Polychronopoulos, P., et al. 2004. J. Med. Chem. 47, 935. Meijer, L., et al. 2003. Chem. Biol. 10, 1255. | 

 


 
  

 

 
 
 
 
 
 
